苏州麦迪斯顿医疗科技股份有限公司2025年第二次临时股东大会决议公告

Meeting Summary - The second extraordinary general meeting of shareholders was held on October 13, 2025, at the company's conference room in Suzhou, Jiangsu Province [2] - The meeting was presided over by Vice Chairman Mr. Weng Kang, and voting was conducted through a combination of on-site and online methods [2][3] - All directors, supervisors, and the board secretary attended the meeting, ensuring full representation [3] Resolutions Passed - The proposal regarding the "Fourth Employee Stock Ownership Plan (Draft)" was approved [4] - The proposal concerning the "Management Measures for the Fourth Employee Stock Ownership Plan (Draft)" was also approved [5] - The proposal to authorize the board of directors to handle matters related to the fourth employee stock ownership plan was passed [5] Legal Verification - The meeting was witnessed by Beijing Zhonglun (Shanghai) Law Firm, and the lawyers confirmed that the meeting's procedures complied with relevant laws and regulations [6] Financial Management Update - The company approved the use of up to RMB 200 million of idle raised funds for cash management, ensuring it does not affect the progress of investment projects [8] - As of September 30, 2025, the company redeemed RMB 70 million from a bank deposit, earning a financial return of RMB 19,000 [9] - The remaining balance of idle raised funds used for cash management is RMB 35 million, with no overdue amounts reported [9]